🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We're pleased to share findings from work published in Nature Portfolio's Nature Genetics, in partnership with our collaborators, to discover gene-metabolite associations and how they impact human traits and disease, including #kidneydisease. This work included studies to

At Maze, we recognize that innovation in medicine must go hand in hand with equity in access. This #BlackHistoryMonth, our director of patient advocacy and community engagement Danielle Branch, MBA, led a conversation about the important role patient advisory groups play as a

On #RareDiseaseDay, we recognize and draw attention to the challenges faced by those living with a rare diseases, and we stand with the #raredisease community in bringing awareness and seeking solutions to often overlooked or underserved conditions. At Maze, we are committed to

This #InternationalWomensDay, we’re celebrating women who inspire one another and #AccelerateAction by advancing science and shaping culture. Some members of the Maze team have shared what it means to them to lead with purpose and create lasting impact in the work we do every

In honor of #WomensHistoryMonth, we hosted a company panel focused on the experiences of women in science, the most meaningful lessons learned and strategies for overcoming challenges. This year's theme “Moving Forward Together! Women Educating & Inspiring Generations" embodies

Today we announced fourth quarter and year-end 2024 financial results and highlighted recent progress and upcoming milestones. Learn more about the meaningful progress we are making with our two clinical-stage programs — MZE829 in APOL1 #kidneydisease and MZE782 in chronic kidney

On behalf of Maze, our Director of Patient Advocacy and Community Outreach Danielle Branch participated in AL Kidney Foundation’s (AKF) #HuntsvilleKidneyWalk. Maze was a proud sponsor of the event which supported local #kidneydisease patients in need and helped to fund treatment

APOL1 kidney disease refers to chronic #kidneydisease in patients with APOL1 gene variants. All individuals inherit two copies of the APOL1 gene. However, certain changes in this gene can raise the risk of chronic kidney disease—particularly in people of African ancestry. At

This #DNADay, we’re celebrating the power of genetics to unlock new possibilities in medicine and the people pushing science forward. We were honored to host Dr. Doug Fowler, professor of Genome Sciences and Bioengineering at the University of Washington, for a seminar on measuring human genetic

In honor of APOL1 Awareness Day, we're proud to share a new resource for the APOL1 #kidneydisease community. This resource provides accessible, expert-informed information for individuals and families affected by APOL1 kidney disease, especially those of African ancestry, who are

At Maze, we believe that even small actions can make a big impact when it comes to protecting our planet. To celebrate #EarthDay, our team came together last week for a day of sustainable activities including a clothing, toy, and household item swap, a plant swap, and delicious

We are pleased to introduce you to Maze's patient advisory committee (PAC), comprised of representatives and allies of the APOL1 #kidneydisease and chronic kidney disease (CKD) patient communities. This committee ensures that the voices of patients and caregivers are at the

Our CEO Jason Coloma, Ph.D., will present a company overview at the 3rd Annual H.C. Wainwright BioConnect Investor Conference next Tuesday at 11 a.m. ET.  A live webcast will be available in the Investors section of our website and archived for 60 days following the presentation.

Today we reported financial results for the first quarter ended March 31, 2025, and reiterated upcoming milestones. Read the full announcement here: ir.mazetx.com/news-releases/…

On #ClinicalTrialsDay, we recognize those who make clinical progress possible. Our science starts with genetics, but it’s driven by something deeply human: a strong commitment to improving lives. Our HORIZON trial reflects this mission and is the first study of a #small molecule

During #PKUAwareness Month and every month, we stand with the PKU community. Phenylketonuria (PKU) is a rare genetic disorder that requires lifelong management. At Maze, we’re advancing research with the goal of easing that burden. Our investigational therapy, MZE782, is an oral

Our CEO Jason Coloma, Ph.D., will present a company overview at the 2025 #JefferiesHealthcare Conference on Thursday, June 5, 2025, at 2 p.m. ET. A live webcast will be available in the Investors section of our website and archived for 60 days following the presentation.

To celebrate Asian American, Native Hawaiian, and Pacific Islander Heritage Month, Mazers gathered for a special game night that honored the rich traditions of #AANHPI communities. We focused on the theme of resilience and rebuilding and how cherished cultural traditions like

Mazers recently stepped up for the @NKF Northern California Kidney Walk and made it count. We’re proud to have surpassed our fundraising goal, setting a new company record and earning a spot among the event’s top fundraisers. A heartfelt thank you to everyone who donated, walked,

Today, Maze honors #Juneteenth, a pivotal moment in U.S. history that commemorates the end of slavery and calls us to reflect on the ongoing pursuit of equity and justice. Our offices are closed in recognition of this day — a time to pause, learn, and consider how we, as